NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic Alterations

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

June 28, 2024

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Non-squamous Metastatic Non-Small-Cell Lung Carcinoma
Trial Locations (18)

Unknown

RECRUITING

Research Site, Bad Homburg

RECRUITING

Research Site, Berlin

RECRUITING

Research Site, Celle

RECRUITING

Research Site, Chemnitz

RECRUITING

Research Site, Georgsmarienhütte

WITHDRAWN

Research Site, Gera

RECRUITING

Research Site, Goslar

RECRUITING

Research Site, Halle-Dolau

RECRUITING

Research Site, Hanover

RECRUITING

Research Site, Herne

RECRUITING

Research Site, Koln-Mehrheim

RECRUITING

Research Site, Münnerstadt

RECRUITING

Research Site, Neuss

RECRUITING

Research Site, Ravensburg

RECRUITING

Research Site, Treuenbrietzen

RECRUITING

Research Site, Ulm

RECRUITING

Research Site, Wiesbaden

RECRUITING

Research Site, Zwickau

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY